Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

Cardiovascular diseases (CVD) remain the leading cause of death globally, and further
efforts are being undertaken to understand and modify CVD risk factors, such as …

Background: Emerging evidence suggests that elevated circulating levels of HDL-C (high-
density lipoprotein cholesterol) could be linked to an increased mortality risk. However, to …

Context Among children, evidence on long-term longitudinal associations of accelerometer-
measured sedentary time, light physical activity (LPA), and moderate to vigorous PA (MVPA) …

Importance Increased levels of high-density lipoprotein cholesterol (HDL-C) have been
associated with osteoporosis. Preclinical studies have reported that HDL-C reduces bone …

Alterations affecting high-density lipoproteins (HDLs) are one of the various abnormalities
observed in dyslipidemia in type 2 diabetes mellitus (T2DM) and obesity. Kinetic studies …

High-density lipoprotein (HDL) contributes to reverse cholesterol transport, which is 1 of the
main explanations for the described inverse association between HDL-cholesterol (HDL-C) …

Background Elevated triglyceride levels are a clinically useful marker of remnant cholesterol.
It is unknown whether triglycerides are associated with residual cardiovascular risk in CVD …

Background Women with peripheral artery disease (PAD) often have atypical symptoms, late
hospital presentations, and worse prognosis. Risk factor identification and management are …

Aim Although lipoproteins are well‐established risk factors for cardiovascular disease (CVD)
mortality, conventional measurements failed to identify lipoprotein particle sizes. This study …